Compile Data Set for Download or QSAR
Report error Found 10 Enz. Inhib. hit(s) with all data for entry = 5941
TargetInsulin-like growth factor 1 receptor(Human)
Novotyr Therapeutics

US Patent
LigandPNGBDBM101912(US8536227, 4)
Affinity DataIC50: 30nMAssay Description:Inhibition assay using IGF1R activity in a cell free kinase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetInsulin-like growth factor 1 receptor(Human)
Novotyr Therapeutics

US Patent
LigandPNGBDBM5567(US8536227, 8)
Affinity DataIC50: 50nMAssay Description:Inhibition assay using IGF1R activity in a cell free kinase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetInsulin-like growth factor 1 receptor(Human)
Novotyr Therapeutics

US Patent
LigandPNGBDBM101913(US8536227, 5)
Affinity DataIC50: 70nMAssay Description:Inhibition assay using IGF1R activity in a cell free kinase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetInsulin-like growth factor 1 receptor(Human)
Novotyr Therapeutics

US Patent
LigandPNGBDBM101914(US8536227, 6)
Affinity DataIC50: 80nMAssay Description:Inhibition assay using IGF1R activity in a cell free kinase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetInsulin-like growth factor 1 receptor(Human)
Novotyr Therapeutics

US Patent
LigandPNGBDBM101916(US8536227, 10)
Affinity DataIC50: 90nMAssay Description:Inhibition assay using IGF1R activity in a cell free kinase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetInsulin-like growth factor 1 receptor(Human)
Novotyr Therapeutics

US Patent
LigandPNGBDBM5846(US8536227, 12)
Affinity DataIC50: 120nMAssay Description:Inhibition assay using IGF1R activity in a cell free kinase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetInsulin-like growth factor 1 receptor(Human)
Novotyr Therapeutics

US Patent
LigandPNGBDBM101917(US8536227, 11)
Affinity DataIC50: 140nMAssay Description:Inhibition assay using IGF1R activity in a cell free kinase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetInsulin-like growth factor 1 receptor(Human)
Novotyr Therapeutics

US Patent
LigandPNGBDBM5720(US8536227, 9)
Affinity DataIC50: 170nMAssay Description:Inhibition assay using IGF1R activity in a cell free kinase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetInsulin-like growth factor 1 receptor(Human)
Novotyr Therapeutics

US Patent
LigandPNGBDBM101915(US8536227, 7)
Affinity DataIC50: 180nMAssay Description:Inhibition assay using IGF1R activity in a cell free kinase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetInsulin-like growth factor 1 receptor(Human)
Novotyr Therapeutics

US Patent
LigandPNGBDBM5921(US8536227, 13)
Affinity DataIC50: 220nMAssay Description:Inhibition assay using IGF1R activity in a cell free kinase assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent